Pharmaceuticals, Biotechnology and Life Sciences
Arvinas and Pfizer plan to jointly select third party for the out-licensing and commercialization of vepdegestrant Additional cost optimization measures…
Postpartum depression is a leading cause of maternal mortality in Europe1-2, and is one of the most common medical conditions…
CAMBRIDGE, Mass., Sept. 17, 2025 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of…
Data show a favorable safety profile and early efficacy signals in a heavily pre-treated population whose cancer progressed after multiple…
In process of adopting a Director stock ownership policy to reinforce commitment of aligning the Board’s interests with stockholders Vaxart encourages…
REDWOOD CITY, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare…
Representing 10 U.S. states and Puerto Rico, finalists will compete in Washington, D.C., for more than $100,000 in awards Meet…
Complete 26-week results further demonstrate that combining semaglutide with trevogrumab (anti-GDF8/anti-myostatin) helped prevent about half of semaglutide-induced loss of lean…
NESS ZIONA, Israel, Sept. 17, 2025 (GLOBE NEWSWIRE) — Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company…
Nylon and Polyester Are Polluting the Planet with MicroplasticsDENVER, Sept. 17, 2025 (GLOBE NEWSWIRE) — 247marketnews.com, a pioneer in digital…